Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
Adult Immunization
SK Sharma, A Muruganathan, Dilip Mathai, Milind Y Nadkar
1:
Setting-up an Adult Immunization Clinic
Introduction
Stepwise Approach in Setting Adult Immunization Clinic
Step 1: Create a Workspace for Vaccine Clinic
Step 2: Proper Vaccine Storage and Handling
Step 3: Determine the Personnel
Step 4: Administering Vaccines
Step 5: Documentation
Conclusion
2:
Principles of Immunization
Introduction
Active and Passive Immunity
Immunization and Vaccination
Immunization Strategies
Use of Immunogens and Adjuvants
Passive Immunization
Vaccination
Vaccine
Live-attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
Conclusion
3:
Adolescent Immunization
Who are Adolescents? Why are they Important?
Why Adolescent Vaccination?
Concept of Adolescent Immunization
Human Papilloma Virus Vaccine
Tetanus, Diptheria, Acellular Pertussis (Tdap) Vaccine
Meningococcal Vaccine
Hepatitis B Vaccine
Measles, Mumps, Rubella Vaccine
Varicella Vaccine
Hepatitis A Vaccine
Typhoid Vaccine
Japanese Encephalitis Vaccine
Haemophilus influenzae Type b Vaccine
Influenza Vaccine
Pneumococcal Vaccine
4:
Anthrax
Epidemiology
Transmission
Clinical Features
Cutaneous
Inhalational
Intestinal
Other Sites
Diagnosis
Bacteriologic Tests
Serologic and Immunologic Tests
New Molecular Diagnostic Methods
Treatment
Prevention
Global Scenario of the Vaccine
Anthrax Vaccine
Sterne's Vaccine
Russian Anthrax Vaccine
British Anthrax Vaccine
American Anthrax Vaccine
Recombinant Vaccine
Current Vaccine
Indications
Pre-exposure Vaccination
Occupational and Laboratory Exposures
Bioterrorism Preparedness
Vaccine Safety
Vaccine Future
Vaccination Recommendations
5:
Cancer Vaccines
Introduction
Cancer Epidemiology
Need for a Vaccine
Cancer Vaccines
Preventive Cancer Vaccines
Therapeutic Cancer Vaccines
Global Vaccine Scenario
Conclusion
6:
Chikungunya
Disease Burden
Introduction
Clinical Features
Acute Stage
Chronic Stage
Risk Factors
Epidemiology
Transmission
Drug Resistance Issues
Management Challenges
Challenges in Diagnosis
Differential Diagnosis
Diagnosis
Treatment Challenges
Management
Newer Developments
Passive Immunization
Antiviral Therapy
Prevention and Control
Need for Chikungunya Vaccine and the Present Global Scenario
Cost-Effectiveness
Vaccine Development Including Safety Issues
Killed Vaccines
Live-attenuated Vaccines
Recombinant Vaccines
Vaccine Future
Conclusion
7:
Cholera Vaccines
Disease Epidemiology
Need of Vaccine
Cholera Vaccines
Injectable Cholera Vaccine
Oral Cholera Vaccine
Global Scenario of Cholera Vaccines
Dukoral™
Shanchol™
Vaccine Safety
Dukoral™
Shanchol™
Cost-Effectiveness
Indian Recommendations
Indian Perspective
8:
Dengue Fever and Present Status of Dengue Vaccine
Introduction
Epidemiology
Transmission of the Dengue Virus
Predisposition
Clinical Manifestations
Associated Problems
Dengue Virus Antigens and Immune Response
Need for Vaccination
Current Vaccination
Future of Vaccination
Chimeric Dengue Vaccine
Live-attenuated Virus Vaccines17
Conclusion
9:
Hepatitis A Vaccine
Introduction
Epidemiology
Need of Vaccine
Current Vaccines
Vaccines Source and Preparations
Immunogenicity
Dosing Schedule
Global Scenario of the Vaccine
Recommendations
International Travel
Vaccine Safety
Contraindications
Cost-Effectiveness
Indian Recommendations
10:
Hepatitis B Vaccine
Epidemiology
Burden of HBV Infection in India
Chronic HBV Positivity Rate in India
Need of Vaccine
Immunization against HBV
HBV in Pregnant Women
Adults at Risk for HBV Infection (Box 1)
Persons at Risk for Infection by Sexual Exposure
Persons at Risk for Infection by Percutaneous or Mucosal Exposure to Blood Injection-Drug Users
Household Contacts of Persons with Chronic HBV Infection
Inmates and Staff of Institutions for Developmentally Disabled Persons in Long-term Care Facilities
HBV in Health Care Workers
Chronic Renal Failure Patients
Recipients of Blood Products
Persons with Chronic Liver Disease
HIV Positive Persons
Current Vaccines
Immune Memory
Vaccination of High-Risk Groups
Poor or Nonresponse to HBV Vaccination, Postvaccination Screening and Response to Revaccination
Groups Requiring Different Vaccination Doses or Schedules (Table 2)
Booster Doses
Prevaccination Serologic Testing for Susceptibility
Indian Recommendations
Summary
Burden of HBV in India
Immunization
Immunological Response
Prevaccination Serologic Testing for Susceptibility
11:
Hepatitis C Vaccine
Disease Epidemiology
Need of Vaccine
Challenges
Current HCV Vaccines
Prophylactic Vaccines: Global Scenario
Recombinant Protein Vaccines
DNA and Vector Vaccines
Therapeutic Vaccines: Global Scenario
Recombinant Protein Vaccines
Envelope Protein Vaccines
Core Proteins
Peptide Vaccines
DNA Vaccines
Biolistic Technology (Biological Ballistic or “Gene Gun”)
Electroporation
Vector Vaccines
Vaccine Safety and Cost-Effectiveness
Vaccine Future
Indian Recommendations
Conclusion
Prophylactic Vaccines
DNA and Vector Vaccines
Therapeutic Vaccines
Peptide Vaccines
DNA Vaccines
Vector Vaccines
12:
Hepatitis E Vaccine
Epidemiology
Genome, Genetic Heterogeneity
Immunobiology of Hepatitis E Virus
Need of Vaccine
Current Vaccine
Global Scenario of the Vaccines
Immunoprophylaxis
Rationale Behind Hepatitis E Vaccine Development
Possible Vaccine Candidates
Recombinant Proteins Expressed in Prokaryotes
Proteins Expressed in Insect Cells
Expression in Yeast Cells
Proteins Expressed in Plant Cells
Clinical Trials of Hepatitis E Vaccine Candidates
Phase I/II Trials of the 56 kDa Vaccine
Phase II/III Trials of the HEV 239 Vaccine
Nucleic Acid Based Vaccines
Conclusion
Summary
Hepatitis E Virus
Seroprevalence
Immunoprophylaxis
Vaccines
13:
Haemophilus Influenzae Type B Vaccination for Adults
Disease Epidemiology1
Risk Groups
Need for Vaccine7
History of Hib Vaccine
Efficacy of Clinical Study
Correlates of Protection
Current Vaccines
Administration and Scheduling
Recommendations
Selected Conditions for which H. influenzae Type B vaccine May be Used
Association of Physicians of India Recommendation
14:
Human Papillomavirus Vaccine for Adults (HPV Vaccines)
Epidemiology and Burden of Human Papillomavirus Disease: Current Status
Need for Vaccine
Type of Vaccines Available
Efficacy Data
The Quadrivalent Vaccine
The Bivalent Vaccine
Measuring Vaccine Effectiveness
Real World Effectiveness Data
Impact of Human Papillomavirus Vaccination in Australian Population
Impact of Human Papillomavirus Vaccination in USA Population
Human Papillomavirus Vaccine: Global Scenario
Safety of Human Papillomavirus Vaccine
PATH Study in India
Cost-Effectiveness
Economic Evaluation Based on Transmission Model
Key Findings
Future in Human Papillomavirus Vaccine
Two Doses Schedule
Guidelines for Special Population: Adolescents and Adults
Recommendation
ACIP Recommendation34–37
In India
Indian Academy of Pediatrics38
Federation of Obstetrics and Gynecology Societies of India39
The Association of Physicians of India
15:
Human Immunodeficiency Virus Vaccine: Changing Paradigms
Introduction
Structure of Human Immunodeficiency Virus and Vaccine Targets
Human Immunodeficiency Virus Specific Immunity may Prevent Disease Progression
Requirement of an Human Immunodeficiency Virus Vaccine
Obstacles for Vaccine Development
Highly Mutable and Genetically Varied Subtypes
Lack of a Suitable Animal Model
Limited Natural Response to Human Immunodeficiency Virus Infection
Lack of Clear Correlates of Protective Immunity
Desired Vaccine Profile
Types of Human Immunodeficiency Virus Vaccines
Whole Inactivated
Live-attenuated
Synthetic Peptide
Recombinant Subunit
Recombinant Viral Vectors
Deoxyribonucleic Acid Vaccines
Supplementary Strategies for Candidate Vaccines
Prime Boost Vaccine
Use of Adjuvant
Multiclade Vaccine
Therapeutic Human Immunodeficiency Virus Vaccine
Outcomes of Completed Efficacy Trials
Current Scenario in Vaccine Development
Ethical Issues in Human Immunodeficiency Virus Vaccine Trials
Future Directions in Human Immunodeficiency Virus Vaccine Development
Human Immunodeficiency Virus in Indian Context and Consequent Challenges
Human Immunodeficiency Virus Vaccine Trials in India
Other Initiatives and Programs
Conclusion
Vaccine Recommendations
Acknowledgment
16:
Influenza Vaccines
Introduction
Disease Epidemiology
Need of Vaccination-Strategies for Controlling Influenza
Current Influenza Vaccines: Global and Indian Scenario
Inactivated Influenza Vaccine
Safety Issues
Live-attenuated Influenza Vaccine
Contraindications
Efficacy, Effectiveness and Protection
Avian or Swine Influenza
17:
Immunization in Pregnant Women
Introduction
Vaccines Contraindicated in Pregnancy (Tables 1 and2)
Hepatitis A
Hepatitis B
Human Papillomavirus
Influenza (Inactivated)
Influenza Live-attenuated Influenza Vaccine
Measles, Mumps, Rubella
Pneumococcal Conjugate
Pneumococcal Polysaccharide
Polio
Tetanus, Diphtheria and Pertussis and Tetanus and Diphtheria
Varicella
Zoster (Shingles)
Anthrax
Bacillus Calmette-Guérin
Japanese Encephalitis
Rabies
Typhoid
Vaccinia (Smallpox)
Yellow Fever
Conclusion
FOOD AND DRUG ADMINISTRATION PREGNANCY CATEGORIES
Pregnancy Category A
Pregnancy Category B
Pregnancy Category C
Pregnancy Category D
Pregnancy Category X
18:
Japanese Encephalitis Vaccines
Disease Epidemiology
Need of Vaccine
Current Japanese Encephalitis Vaccines
Inactivated Mouse Brain-Derived Vaccine (JE-MB)
Cell Culture-Derived Inactivated Vaccine (JE-VC)
Cell Culture-Derived Live-attenuated Vaccine
Global Scenario of JE Vaccines
Inactivated Mouse Brain-Derived Vaccine (JE-MB)
Cell Culture-Derived Inactivated Vaccine (JE-VC)
Cell Culture-Derived Live- attenuated Vaccine
Vaccine Safety
Inactivated Mouse Brain-Derived Vaccine (JE-MB)
Cell Culture-Derived Inactivated Vaccine (JE-VC)
Cell Culture-Derived Live-attenuated Vaccine
Cost-Effectiveness
Vaccine Future
Jenvac (Inactivated JE Vaccine)
Indian Recommendations
19:
Leprosy Vaccines
Introduction
Immunomodulatory Agents Available or Tried in Leprosy
Bacillus Calmette-Guerin
Mycobacterium indicus pranii
International Committee of the Red Cross Strain
Mycobacterium habana
Mycobacterium vaccae
Bacillus Calmette-Guerin Plus Killed Mycobacterium leprae
Comparative Efficacy of Candidate Vaccines against Leprosy
Immunotherapy of Leprosy
Subunit and Deoxyribonucleic Acid Vaccines
Future Perspective
20:
Malaria
Disease Epidemiology
Clinical Features
Diagnosis
Microscopy
Rapid Diagnostic Test
Treatment
Treatment Uncomplicated Malaria
P. vivax Malaria
P. falciparum Malaria
Mixed Infections (P. falciparum + P. vivax)
Special Circumstances
Antimalarial Drug Resistance
Need of Vaccine/Indication
Current Vaccine
Vaccine Global Scenario
Vaccine Safety
Cost-Effectiveness
Vaccine Future
21:
Measles, Mumps and Rubella (MMR) Vaccination
Introduction
Measles, Mumps and Rubella Vaccine
History
Current Measles, Mumps and Rubella Vaccines
Efficacy
Adverse Reactions
Contraindications
MMR Vaccine: Need in Adults
Measles
Mumps
Rubella
22:
Meningococcal Vaccine
Introduction
Risk Factors for Meningococcal Disease
Meningococcal Disease and Vaccination
Polysaccharide Vaccines
Conjugate Vaccines
Vaccine Availability in India
Vaccine Administration, Contraindications and Adverse Effects
Polysaccharide Vaccine
Conjugate Vaccine
Vaccine Efficacy, Immunogenicity and Kinetics of Immune Response
Vaccination Guidelines for Adults in India
Future Vaccine Development
23:
Newer Vaccines
Introduction
Human African Trypanosomiasis
Disease Epidemiology
Need of Vaccine/Indication
Vaccine Global Scenario, Vaccine Safety, Cost-Effectiveness and Vaccine Future
Cytomegalovirus
Disease Epidemiology
Need of Vaccine/Indication
Vaccine Global Scenario, Vaccine Safety, Cost-Effectiveness
Vaccine Future
Smallpox and Anthrax Combined Vaccine
Disease Epidemiology
Need of Vaccine/Indication
Vaccine Global Scenario, Vaccine Safety, Cost-Effectiveness and Vaccine Future
Hookworm
Disease Epidemiology
Need of Vaccine/Indication
Vaccine Global Scenario, Vaccine Safety, Cost-Effectiveness and Vaccine Future
Schistosomiasis
Disease Epidemiology
Need of Vaccine/Indication
Vaccine Global Scenario, Vaccine Safety, Cost-Effectiveness and Vaccine Future
Conclusion
24:
Pneumococcal Vaccine
Introduction
Burden of Pneumococcal Infections
Risk Factors for Pneumococcal Infections
Streptococcus pneumoniae and Pneumococcal Vaccines
Pneumococcal Vaccine in High-Risk Groups
HIV Infection
Asplenia
Solid Organ Transplant Candidates and Recipients
Chronic Obstructive Pulmonary Disease
Cost-effectiveness of Pneumococcal Vaccines
Vaccine Administration and Adverse Effects
Recommendations for Use of Pneumococcal Vaccines Among Adults in India
Future Vaccine Development
25:
Immunization for Poliomyelitis in Adults: Indian Guidelines
Disease Epidemiology
Need of Vaccines
Current Vaccines
Vaccine Safety
Global Scenario of Polio
The Future
Recommendations for India
Conclusion
26:
Rabies Immunization
Introduction
Disease Epidemiology
Burden of the Disease
Modes of Transmission
Need of Vaccination
Indications of Vaccination, Safety and Cost-Effectiveness of Vaccines Post-exposure Treatment
Decision to Treat
Management of Animal Bite Wound
Passive Immunization by Rabies Immunoglobulin
Active Immunization
Intramuscular regimens
Postexposure Therapy for Previously Vaccinated Persons
Managing Re-exposure Following Postexposure Treatment with Tissue Culture Vaccines
Managing Exposure Following Pre-exposure Prophylaxis with Tissue Culture Vaccines
Managing Re-exposure Following Postexposure Treatment with Nervous Tissue Vaccine
Protective Level of Antirabies Antibody
Role of Laboratory Facilities in Management of Animal Bite Cases
Pre-exposure Prophylaxis
Counseling of Patients and Attendants
Effectiveness of Vaccination in Dogs
Personal Safety Against Rabies
Possible Reasons for Antirabies Treatment Failure
Control of Rabies in Reservoir
27:
Rotavirus Vaccines
Introduction
Microbiology
Rotavirus Epidemiology in India
Rotavirus Infection and Immune Response
Is the Protection to Rotavirus Disease Induced by Vaccines Serotype Specific?
Mechanism of Disease
Development of Vaccines to Protect from Rotavirus Infection
Historical Overview of Rotavirus Vaccines
Global Vaccine Scenario
RotaTeq® (Pentavalent Live Oral Human-Bovine, WC3 Reassortants)
Coadministration of RotaTeq® with Childhood Vaccines
Rotarix® (Monovalent Human G1 Rotavirus Vaccine)
Coadministration of Rotarix® with Childhood Vaccines
116E Neonatal Strain Vaccine
Other Candidate Rotavirus Vaccines
Rotashield® [Quadrivalent Live Oral Human-Rhesus (RRV) Reassortant]
Other Approaches to Rotavirus Vaccination
Vaccine Safety
Cost-Effectiveness
Need for Rotavirus Vaccine
Introduction of Rotavirus Vaccine in India
28:
Tetanus, Diphtheria, Pertussis (Tdap Vaccine) Vaccination in Adults
Introduction
Epidemiology of Disease
Tetanus
Diphtheria
Pertussis
Epidemiology
Indications for Td or Tdap Vaccination
Routine Immunization
Dose and Route
Storage and Handling
Efficacy and Effectiveness
Contraindications and Precautions
Contraindications
Precautions
Adverse Effects
Vaccine Preparations
Immunization for Patients with Injuries
Pertussis: Strategies to Prevent Outbreaks
Healthcare Personnel
Other Control Measures
Conclusion
29:
Tuberculosis Vaccine
Epidemiology of Tuberculosis
Need for Vaccine
Current Vaccine: Bacillus Calmette-Guérin
Global Scenario of Tuberculosis Vaccine
Prime
Prime-boost
Immunotherapeutic
Vaccine Candidates
Live Recombinant (Prime) Vaccine Candidates
Viral Vector Vaccine
Adjuvanted Subunit Vaccine
Whole-cell or Fragmented Mycobacterial Vaccine
Indian Studies
Vaccine Safety and Cost-Effectiveness
Vaccine Future
Indian and World Recommendation
Conclusion
30:
Typhoid Vaccines
Disease Epidemiology
Need of Vaccine
Current Typhoid Vaccines
Vi Polysaccharide Vaccine
Ty21a Oral Vaccine
Global Scenario of Typhoid Vaccines
Vi Polysaccharide Vaccine
Ty21a Oral Vaccine
Vaccine Safety
Vi Polysaccharide Vaccine
Ty21a Oral Vaccine
Cost-Effectiveness
Vaccine Future
Typbar TCV™ (Vi-TT Conjugate Vaccine)
Indian Recommendations
31:
Vaccines for Travelers, Immigrants and Migrants: Indian Guidelines
Introduction
Assessment of the Need for Travel Vaccines
Categories of Travel Vaccines
Routine Immunizations
Hepatitis B
Diphtheria, Tetanus and Pertussis
Measles and Mumps
Polio
Varicella
Recommended Vaccines
Hepatitis A
Combination Hepatitis A and Hepatitis B Vaccine
Influenza
Pneumococcal Disease
Typhoid
Rabies
Japanese Encephalitis
Meningococcus
Cholera
Tick-Borne Encephalitis
Required Vaccine
Yellow Fever
Contraindications
Vaccinations for Mass Gathering
Travelers to India
Important Notice for all Travelers Visiting India—Oral Polio Vaccination Mandatory with Effect From 30.01.2014
32:
Vaccination Recommendations for Solid Organ Transplantation and Chronic Kidney Disease
Introduction
Timing of Immunizations
Hepatitis B Vaccine
Recommendations
Timing of Vaccination
Types of Vaccine
Dose and Schedule
Immunogenicity
Vaccine Efficacy
Revaccination of Nonresponders
Screening
Hepatitis A Vaccine
Dose Regimens
Rationale
Pneumococcal Polysaccharide Vaccine
Vaccines
Dose Schedule
Rationale
Influenza Vaccine
Dose Recommendations48
Rationale
Recommendations Regarding Other Routine Vaccines
Live-attenuated Vaccines
Varicella Vaccination
Dose Schedule
Optimal Timings for Chronic Kidney Disease Patients
Rationale
Zoster Vaccine
Measles, Mumps and Rubella Vaccine
Dose and Timings of Vaccination
Rationale
Use of Inactivated Vaccine and Toxoids in Dialysis
Dose
Rationale
Diphtheria and Tetanus Toxoids and Pertussis Vaccine
Rationale
33:
Varicella and Herpes Zoster Vaccine: Indian Guidelines
Epidemiology of Varicella
Tropical Countries
India
Indications for the Vaccine (Adults: 18 Years of Age and Older up to 50 years)
Current Vaccines
Global Scenario of Vaccine
Vaccine Safety
Cost-Effectiveness
Future of Vaccine
Indian Recommendations
Resource Rich Settings
Resource Poor Settings Susceptible
Herpes Zoster Vaccination
Epidemiology
Indications of the Vaccine
Current Vaccines
Global Scenario
Vaccine Safety
Cost-Effectiveness
Future of Zoster Vaccine
Indian Recommendation
Conclusion
34:
Visceral Leishmaniasis: Current Problems and Prospect of an Effective Vaccine
Introduction
Disease Burden
Clinical Presentation
Risk Factor
Epidemiology
Drug Resistance Issues
Need for Vaccine/Indication
Types of Vaccine Candidates
Live Virulent Parasite
First Generation Vaccine
Second Generation Vaccine
Third Generation Vaccine
Genetically Modified Attenuated Parasite
Indian Recommendations
Conclusion
35:
Yellow Fever Vaccine for Adults
Epidemiology of Yellow Fever
Geographic Distribution and Spread
Incidence and Burden of Disease
Age-Specific Patterns
Yellow Fever Vaccine
Correlates of Protection
Immunogenicity and Effectiveness
Safety
General Events
Administration of Yellow Fever Vaccine
Recommendation for Vaccination
Personnel in Special Labs and Military
Requirements for Vaccination before International Travel
Primary Vaccination
Booster Doses
Special Groups to be Considered for Vaccination
API Recommendations
36:
Technical Aspects of Vaccination Administration
Introduction
Staff Training and Education
Patient Preparation and Care
Screening
Vaccine Safety and Risk Communication
Atraumatic Care
Infection Control
Route and Site
Peroral Route
Intranasal Route
Subcutaneous Route
Site
Needle Gauge and Length
Technique
Intramuscular Route
Site
Needle Gauge
Needle Length
Infants (Younger than 12 Months)
Toddlers (12 Months Through 2 Years)
Children/Adolescents (3 Years Through 18 Years)
Adults (19 Years and Older)
Technique
Intradermal Route
Site
Needle Gauge and Length
Technique
Vaccines with Diluents (Table 3)
INDEX
TOC
Index
×
Chapter Notes
Save
Clear